Steve Brine

This is a matter for schools to decide. We have empowered schools to lead the delivery of high-quality professional development for their teachers through the creation of the national network of teaching schools, and we are supporting this through the development of a new Standard for Teachers’ Professional Development. Decisions relating to teachers’ professional development rightly rest with schools, head teachers, and teachers themselves, as they are in the best position to judge their own requirements.

The School Teachers’ Pay and Conditions Document specifies that teachers must be available for work for 195 days each year and that they may only be required to perform duties other than teaching pupils on five of those days. It is for schools to decide for themselves how best to make use of those five days, including whether they should be used for in-service training.

We are investing £5 billion over this Parliament to support local authorities in their duty to secure sufficient school places for their area.

This has already enabled local authorities to create 260,000 additional pupil places between May 2010 and May 2013, including 212,000 primary places, with more in the pipeline for September 2015.

All pregnant women receive a Personalised Care and Support Plan, which is a series of facilitated conversations in which the person actively gets involved to explore the management of their health and well-being, taking into account individual needs and requirements, including pre-existing health conditions.

Further to this, NHS England have developed 14 Maternal Medicine Networks across England, to ensure that all women with chronic and acute medical problems around pregnancy, including diabetes, have access to specialist management and care from physicians and obstetrics.

With relation to human immunodeficiency virus (HIV), the Specialised Adult HIV Service Specification sets out the requirements for service providers to support the appropriate management of people living with HIV, including pregnant women with HIV, through referral to and liaison with primary care for management of non-HIV care needs. Service providers are required to ensure that pathways are in place for access to other specialties.

Section 31 of the Health and Care Act 2022 introduced duties on the Care Quality Commission to conduct reviews and assessments of integrated care systems. The government is preparing to make a Commencement Statutory Instrument that will commence these duties on 1 April 2023.

We continue to work with the UK Health Security Agency, local authorities and NHS England to monitor the impact of monkeypox on sexual health services and maintain access to routine sexual and reproductive health (SRH) services, including HIV pre-exposure prophylaxis and contraception.

We have allocated more than £3 billion to local authorities in England to fund public health services, including SRH services, through the Public Health Grant in 2022/23. It is for individual local authorities to determine spending priorities based on an assessment of local need, including for SRH services. In addition, we have provided funding for antiviral medicines to treat monkeypox, the procurement of the smallpox vaccine and for sexual health services to deliver this vaccine to those eligible for vaccination.

We continue to work with the UK Health Security Agency, local authorities and NHS England to monitor the impact of monkeypox on sexual health services and maintain access to routine sexual and reproductive health (SRH) services, including HIV pre-exposure prophylaxis and contraception.

We have allocated more than £3 billion to local authorities in England to fund public health services, including SRH services, through the Public Health Grant in 2022/23. It is for individual local authorities to determine spending priorities based on an assessment of local need, including for SRH services. In addition, we have provided funding for antiviral medicines to treat monkeypox, the procurement of the smallpox vaccine and for sexual health services to deliver this vaccine to those eligible for vaccination.

We continue to work with the UK Health Security Agency, local authorities and NHS England to monitor the impact of monkeypox on sexual health services and maintain access to routine sexual and reproductive health (SRH) services, including HIV pre-exposure prophylaxis and contraception.

We have allocated more than £3 billion to local authorities in England to fund public health services, including SRH services, through the Public Health Grant in 2022/23. It is for individual local authorities to determine spending priorities based on an assessment of local need, including for SRH services. In addition, we have provided funding for antiviral medicines to treat monkeypox, the procurement of the smallpox vaccine and for sexual health services to deliver this vaccine to those eligible for vaccination.

The Government continues to be guided by the advice of the independent Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccinations.

On 15 July 2022, the Government accepted the JCVI’s advice to offer an autumn booster vaccination to increase immunity in those at higher risk from COVID-19 and protect against severe illness, hospitalisation and death in winter 2022/23. The booster dose will be offered to residents and staff in a care home for older adults; all adults aged 50 years old and over; those aged five to 49 years old in a clinical risk group or who are household contacts of someone with immunosuppression; frontline health and social care workers; and carers aged 16 years old and over.

The total number of people on waiting lists for non-urgent treatment in England and Hampshire Hospitals NHS Foundation Trust is shown in the following table.

At the beginning of each financial year, the Mandate sets out NHS England’s total revenue resource limit and total capital resource limit which is then later revised towards the end of the same financial year for any in-year changes in funding.

For 2016-17, the total initial revenue resource limit was £106,496 million and the total capital resource limit was £305 million. This is the budget that was in effect on 23 June 2016. The totals were subsequently revised to £106,528 million for revenue and £260 million for capital.

For 2020-21 as per the opening Mandate, the total revenue resource limit is £129,681 million, including funding for pensions revaluation, and the total capital resource limit is £305 million. This is the budget that was in effect on 1 January 2021. These figures do not include additional COVID-19 support funding recently negotiated with HM Treasury through the Supplementary Estimates process and the Mandate will be revised in due course to reflect the final position.

The information is not available in the format requested.

For the period 29 June 2020 to 4 January 2021, 4,618 people under the age of 70 years old died within 28 days of a positive COVID-19 test in England.

The data prior to 29 June is not available in format requested.

You can only travel internationally or within the United Kingdom (UK) where you first have a legally permitted reason to leave home. In addition, you should consider the public health advice in the country you are visiting. If you do need to travel overseas and are legally permitted to do so, for example, because it is for work, even if you are returning to a place you’ve visited before, you should look at the rules in place at your destination at the following link:

https://www.gov.uk/foreign-travel-advice

UK residents currently abroad do not need to return home immediately. However, you should check with your airline or travel operator on arrangements for returning.

If you are visiting the UK, you may return home. You should check whether there are any restrictions in place at your destination.

The investigation into certain tobacco products which contain menthol, being carried out in Sweden in accordance with the European Union Commission’s implementing Regulation (EU) 2016/779, no longer applies to Great Britain. The Department has asked Public Health England to conduct testing analysis of cigarettes on the Great Britain market as part of its investigation of possible breaches of the prohibition of characterising flavours in the Tobacco and Related Products Regulations 2016. Since 20 May 2020 the production or supply of cigarettes with a menthol characterising flavour in the United Kingdom has been prohibited under Regulation 15 of the 2016 Regulations.

The national standards for neonatal care in England are set out in the NHS Toolkit for High Quality Neonatal Services. The standards can be found at the following link:

https://webarchive.nationalarchives.gov.uk/20130123200735/http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_107845

In addition, the British Association of Perinatal Medicine and the National Institute of Clinical Excellence have produced standards regarding neonatal care which can be applied across the United Kingdom.

Public Health England’s national programme Start4Life provides advice and practical guidance to parents-to-be and families with babies and under-fives, to help them adopt healthy behaviours and build parenting skills. The Start4Life website can be accessed at the following link:

https://www.nhs.uk/start4life

Start4Life has been supporting Group B streptococcus Awareness month by posting from social media channels throughout July. The posts have been designed to raise awareness of Group B Strep, testing in pregnancy and the warning signs to look for in newborn babies.

Channels include Facebook, Instagram and Twitter. Start4Life has also been re-sharing posts made by Group B Strep Support, a United Kingdom charity.

As a result of the COVID-19 pandemic, some aspects of the GBS3 trial were stopped temporarily, including the randomisation of sites to the different arms of the trial and recruitment of participants. However, the team continued with other research related tasks to ensure smooth site opening for the trial re-start.

Training, randomisation and opening of sites to the trial requires the full engagement of maternity and microbiology services. The GBS3 trial hopes to randomise the first sites in September and begin recruiting women early in 2021 but this is dependent on the status of services at the time. The National Institute for Health Research (NIHR) has set out the Restart Framework to guide the restart of NIHR research activities which is available at the following link:

https://www.nihr.ac.uk/documents/restart-framework/24886

The data is not held in the format requested.

The data is not held in the format requested.

There are no restrictions in place on individual organisations sourcing personal protective equipment (PPE) from suppliers, providing the PPE is compliant with requirements.